These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 9545108)

  • 41. [Disparate thyroid imaging with 99mTc pertechnetate and radioiodine (author's transl)].
    Koppers B
    Rofo; 1981 Dec; 135(6):717-20. PubMed ID: 6284606
    [No Abstract]   [Full Text] [Related]  

  • 42. Comparison of pertechnetate and radioiodine thyroid scintiscans in thyroid disease.
    Reschini E; Catania A; Ferrari C; Bergonzi M; Paracchi A; Raineri P
    J Nucl Biol Med (1991); 1993 Mar; 37(1):12-7. PubMed ID: 8392382
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Is standard 555 MBq 131I-therapy of hyperthyroidism ablative?
    Bertelsen J; Herskind AM; Sprogøe Jakobsen U; Hegedüs L
    Thyroidology; 1992 Dec; 4(3):103-6. PubMed ID: 1285034
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Determinants of long-term outcome after radioiodine therapy for solitary autonomous thyroid nodules.
    Bolusani H; Okosieme OE; Velagapudi M; Parsons K; Lazarus JH
    Endocr Pract; 2008; 14(5):543-9. PubMed ID: 18753095
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Autonomous functioning thyroid nodules and 131I in diagnosis and therapy after 50 years of experience: what is still open to debate?
    Ronga G; Filesi M; D'Apollo R; Toteda M; Di Nicola AD; Colandrea M; Travascio L; Vestri AR; Montesano T
    Clin Nucl Med; 2013 May; 38(5):349-53. PubMed ID: 23531770
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Compensated 131I-therapy of solitary autonomous thyroid nodules: effect on thyroid size and early hypothyroidism.
    Hegedüs L; Veiergang D; Karstrup S; Hansen JM
    Acta Endocrinol (Copenh); 1986 Oct; 113(2):226-32. PubMed ID: 3022518
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Iodine isotope ¹³¹I therapy for toxic nodular goitre: treatment efficacy parameters.
    Szumowski P; Rogowski F; Abdelrazek S; Kociura-Sawicka A; Sokolik-Ostasz A
    Nucl Med Rev Cent East Eur; 2012 Apr; 15(1):7-13. PubMed ID: 23047567
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of autonomous thyroid nodules: value of percutaneous ethanol injection.
    Di Lelio A; Rivolta M; Casati M; Capra M
    AJR Am J Roentgenol; 1995 Jan; 164(1):207-13. PubMed ID: 7998541
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Thyroid nodules in Graves' disease: classification, characterization, and response to treatment.
    Carnell NE; Valente WA
    Thyroid; 1998 Jul; 8(7):571-6. PubMed ID: 9709909
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Thyroid nodules in Graves' disease: classification, characterization, and response to treatment.
    Carnell NE; Valente WA
    Thyroid; 1998 Aug; 8(8):647-52. PubMed ID: 9737358
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Radioiodine therapy of small, solitary autonomous adenomas].
    Steiner D; Bauer R
    Nuklearmedizin; 1997 Apr; 36(3):76-80. PubMed ID: 9162905
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Color Doppler sonography-guided percutaneous alcohol instillation in the therapy of functionally autonomous thyroid nodules].
    Braun B; Blank W
    Dtsch Med Wochenschr; 1994 Nov; 119(47):1607-12. PubMed ID: 7982370
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Scintigram after TSH in blocked thyroid gland].
    Schröder F; Wisotzki W
    Z Gesamte Inn Med; 1988 Jul; 43(13):364-6. PubMed ID: 3176578
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Refined use of scintigraphy in the evaluation of nodular thyroid disease.
    McHenry CR; Slusarczyk SJ; Askari AT; Lange RL; Smith CM; Nekl K; Murphy TA
    Surgery; 1998 Oct; 124(4):656-61; discussion 661-2. PubMed ID: 9780985
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Discordant imaging of a thyroid nodule with 131I and 99mTc: concordance of 131I and fluorescent scans.
    Thrall JH; Burman KD; Wartofsky L; Corcoran RJ; Johnson MC; Gillin MT
    Radiology; 1978 Sep; 128(3):705-6. PubMed ID: 674642
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Physiopathology of the autonomous thyroid nodule].
    Vigneri R; Catalfamo R; Freni V; Giuffrida D; Gullo D; Ippolito A; Iurato P; Tumino S; La Rosa GL; Regalbuto C
    Minerva Endocrinol; 1993 Dec; 18(4):143-5. PubMed ID: 8190053
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The effective half-life of 131I during the treatment of autonomous thyroid disease with radioiodine].
    Müller B; Bares R; Büll U
    Nuklearmedizin; 1991 Jun; 30(3):71-6. PubMed ID: 1714566
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effect of antithyroid drug pretreatment on acute changes in thyroid hormone levels after (131)I ablation for Graves' disease.
    Burch HB; Solomon BL; Cooper DS; Ferguson P; Walpert N; Howard R
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3016-21. PubMed ID: 11443161
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Assessment of thyroid nodules by technetium-99m-tetrofosmin scintigraphy.
    Akçay G; Uslu H; Varoglu E; Tekin SB; Gündogdu C
    Br J Clin Pract; 1997; 51(1):5-7. PubMed ID: 9158263
    [TBL] [Abstract][Full Text] [Related]  

  • 60. One-year follow-up of Graves' disease treatment by four different protocols of radioiodine administration.
    Calegaro JU; De Freitas Gomes E; Bae SH; Ulyssea R; Casulari LA
    Panminerva Med; 2000 Dec; 42(4):241-5. PubMed ID: 11294085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.